CHINELLO, CLIZIA
 Distribuzione geografica
Continente #
NA - Nord America 8.601
EU - Europa 4.515
AS - Asia 1.149
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
AF - Africa 7
Totale 14.315
Nazione #
US - Stati Uniti d'America 8.441
IT - Italia 1.207
DE - Germania 864
IE - Irlanda 727
CN - Cina 680
SE - Svezia 593
GB - Regno Unito 248
AT - Austria 229
UA - Ucraina 226
HK - Hong Kong 202
CA - Canada 157
VN - Vietnam 86
FI - Finlandia 84
DK - Danimarca 82
FR - Francia 63
IN - India 58
RU - Federazione Russa 45
BE - Belgio 39
NL - Olanda 27
SG - Singapore 26
TR - Turchia 22
PL - Polonia 19
ES - Italia 16
JP - Giappone 16
KR - Corea 14
RO - Romania 14
BR - Brasile 13
TW - Taiwan 12
IR - Iran 11
AU - Australia 10
EU - Europa 10
CZ - Repubblica Ceca 9
CH - Svizzera 7
BG - Bulgaria 5
IL - Israele 5
TH - Thailandia 5
CL - Cile 4
GR - Grecia 4
PH - Filippine 4
AR - Argentina 3
NO - Norvegia 3
SA - Arabia Saudita 3
HR - Croazia 2
LU - Lussemburgo 2
MA - Marocco 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BT - Bhutan 1
EC - Ecuador 1
EG - Egitto 1
KZ - Kazakistan 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 14.315
Città #
Ann Arbor 2.127
Fairfield 773
Chandler 722
Dublin 718
Woodbridge 626
Frankfurt am Main 595
Wilmington 530
Houston 506
Milan 495
Ashburn 462
Dearborn 358
Seattle 309
New York 249
Cambridge 244
Jacksonville 233
Vienna 223
Hong Kong 198
Princeton 175
Nanjing 135
Shanghai 124
Lawrence 63
Altamura 62
Beijing 60
Fremont 59
Nanchang 56
Dong Ket 48
Guangzhou 41
Lachine 40
San Diego 39
Montréal 38
Helsinki 37
Brussels 36
Ottawa 35
Shenyang 28
Toronto 28
Lissone 27
Andover 25
Los Angeles 25
Hebei 23
London 20
Zhengzhou 20
Caronno Pertusella 19
Falls Church 19
Kunming 19
Pune 19
Tianjin 19
Boardman 18
Jiaxing 18
Jinan 18
Cinisello Balsamo 17
Changsha 16
Madison 16
Ningbo 16
Norwalk 16
Brescia 15
Pavia 15
Chicago 14
Edmonton 14
Kiev 13
Ripalta Cremasca 13
Washington 12
Rome 11
Bonndorf 10
Hangzhou 10
Mountain View 10
Taizhou 9
Cagliari 8
Carate Brianza 8
Huizen 8
Monza 8
Napoli 8
Bergamo 7
Brno 7
Kilburn 7
Minamikasugaoka 7
Nürnberg 7
Padova 7
Sacramento 7
Verona 7
Atlanta 6
Kelty 6
Kraków 6
Legnano 6
Lodi 6
Phoenix 6
Redmond 6
San Mateo 6
Segrate 6
Sesto San Giovanni 6
Singapore 6
Augusta 5
Birmingham 5
Cardano al Campo 5
Como 5
Daejeon 5
Hefei 5
Lanzhou 5
Messina 5
Munich 5
Piacenza 5
Totale 11.200
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 407
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 345
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 324
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 321
Differential protein profiling of renal cell carcinoma urinary exosomes 308
Urinary exosomes and diabetic nephropathy: a proteomic approach 283
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 256
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 255
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 252
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 248
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 246
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 242
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 237
The proteomic landscape of renal tumors 234
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 229
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 225
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 221
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 218
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 218
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 217
Mutual Information Optimization for Mass Spectra Data Alignment 216
Robust conclusions in mass spectrometry analysis 214
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 214
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 207
The putative role of MALDI-MSI in the study of Membranous Nephropathy 206
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 203
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 197
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 194
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 193
Tumor size, stage and grade alterations of urinary peptidome in RCC 191
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 187
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 186
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 185
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 185
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 184
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 179
Proteome analysis in thyroid pathology 176
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 170
Analysis of correlation structures in renal cell carcinoma patient data 168
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 167
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 166
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 165
Imaging mass spectrometry: a new tool for kidney disease investigations 164
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 156
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 154
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 153
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 149
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 146
Intraluminal proteome and peptidome of human urinary extracellular vesicles 145
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 144
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 144
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 143
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 142
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 137
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 137
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 133
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 129
A molecular imaging approach to individuate tumour infiltrating lymphocytes 129
Proteomics imaging and the kidney 126
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 123
AQP1 expression analysis in human diseases: Implications for proteomic characterization 122
Immunoreattività e carcinoma renale 119
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 119
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 119
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 118
Characterization of distinguishing regions for Renal Cell Carcinoma discrimination 112
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 108
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 107
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 105
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 103
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 101
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 98
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 92
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 83
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 82
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 81
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 81
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 79
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 77
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 74
Method for the in vitro diagnosis of thyroid diseases 71
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 70
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 67
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 66
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 62
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 60
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 60
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 56
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 55
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 53
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 50
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 49
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 48
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 43
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 42
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 41
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 32
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 32
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 29
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 26
Totale 14.985
Categoria #
all - tutte 41.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019643 0 0 0 0 0 0 0 0 0 0 285 358
2019/20202.884 304 190 182 226 250 349 434 209 267 202 195 76
2020/20212.733 122 148 294 286 220 225 329 292 205 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.084 68 67 106 173 249 652 481 56 144 44 44 0
Totale 15.115